Skip to content

Clinical trials

Hepatitis C trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: Canada Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20042
20059
20065
20078
20085
200910
20109
201120
201214
20133
20148
201514
20165
201710
20183
20191
20201
20212
20223
20232
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Unknown status13
Terminated11
Withdrawn6
Recruiting2
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences19
Bristol-Myers Squibb17
AbbVie10
University Health Network, Toronto10
Vertex Pharmaceuticals Incorporated8
Janssen R&D Ireland5
Debiopharm International SA4
GlaxoSmithKline4
Human Genome Sciences Inc.4
Ottawa Hospital Research Institute4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C144
Hepatitis C, Chronic32
Fibrosis11
Acquired Immunodeficiency Syndrome7
Hepatitis7
Hepatitis B7
HIV Infections6
Bronchiolitis Obliterans Syndrome4
Liver Cirrhosis4
Liver Diseases4

Trials

Showing 76 to 100 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.